Review
Advances in surgery in neonatal complicated congenital heart disease
Zhou Zijie, Luo Kai, Zheng Jinghao
Published 2022-05-25
Cite as Chin J Thorac Cardiovasc Surg, 2022, 38(5): 310-315. DOI: 10.3760/cma.j.cn112434-20201223-00551
Abstract
With the research and summary of the cases, the surgical indications, surgical procedures, and reference values for material selection for the surgical treatment of neonatal complex congenital heart disease are further refined, and the diagnosis and treatment system is further standardized and completed. In order to increase the success rate of surgery, reduce postoperative mortality and postoperative complications, many researchers have proposed improved surgical procedures, some of which have become mature technologies. In addition, in recent years, the surgical age of newborns has gradually advanced and the surgical weight has gradually decreased. In particular, the increasing application of Hybrid therapy has enabled some critically ill, premature, and low birth weight children to survive smoothly to accept surgical correction. This article will review the recent advances in the surgical treatment of neonatal complicated congenital heart disease.
Contributor Information
Zhou Zijie
Department of Cardial Surgery, the Affiliated Children Medical Center of Shanghai to Medicine College of Shanghai Jiao Tong University, Shanghai 200127, China
Luo Kai
Department of Cardial Surgery, the Affiliated Children Medical Center of Shanghai to Medicine College of Shanghai Jiao Tong University, Shanghai 200127, China
Zheng Jinghao
Department of Cardial Surgery, the Affiliated Children Medical Center of Shanghai to Medicine College of Shanghai Jiao Tong University, Shanghai 200127, China